Severe Psoriasis Epidemiology Forecast 2025-2034

According to the World Psoriasis Day Consortium, about 2% to 3% of the global population is affected by some form of psoriasis, including severe psoriasis. This indicates that more than 125 million people worldwide are living with psoriasis. While this condition can develop at any age, it usually appears first between the ages of 15 and 25.

Severe Psoriasis Epidemiology Forecast Report Coverage

The “Severe Psoriasis Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of severe psoriasis. It projects the future incidence and prevalence rates of severe psoriasis across various populations. The study covers age and type as major determinants of the severe psoriasis-affected population. The report highlights patterns in the prevalence of severe psoriasis over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of severe psoriasis in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Severe Psoriasis: Disease Overview

Severe psoriasis refers to cases where the symptoms are extensive, causing physical pain, emotional distress, and social isolation. This type of psoriasis covers large areas of the body and often leads to red, inflamed skin with silvery scales. People with severe psoriasis may also experience intense itching, burning, and pain, and in some cases, joint pain. Studies suggest that the condition might be triggered by a combination of genetic and environmental factors like stress, infections, or skin injuries.

Severe Psoriasis: Treatment Overview

Topical treatments like corticosteroids, vitamin D analogues, and retinoids are commonly used for reducing inflammation. Phototherapy, or light therapy, is also recommended for certain severe psoriasis patients to slow skin cell production. For more severe cases, systemic medications such as methotrexate and cyclosporine are used, which work throughout the body to reduce inflammation. In addition to medical treatments, lifestyle changes can help manage severe psoriasis.

Epidemiology

The severe psoriasis epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for severe psoriasis by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for severe psoriasis and their trends. The data is broken down into specific categories, such as the total diagnosed cases across different age groups and patient pools.

• According to the Psoriasis and Psoriatic Arthritis Alliance, about 65,000 people in the United Kingdom, or approximately 1 out of 20 individuals (5%) with psoriasis, are affected by severe psoriasis.
• A 2021 cross-sectional study conducted in the United States, which included 12,625 participants, found that 21.5% of participants reported having moderate to severe psoriasis.
• In the United Kingdom, psoriasis affects around 2 in 100 people across all levels of severity. It can develop at any age and occurs in both men and women equally.
• Around 2% to 4% of people in Western countries are estimated to have psoriasis. The incidence is estimated to vary significantly by region, ranging from 0.09% to 11.43%.

Country-wise Severe Psoriasis Epidemiology

The Severe Psoriasis epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of severe psoriasis varies significantly between countries due to differences in genetic predispositions, environmental factors (sunlight exposure, air pollution, and temperature), healthcare access, and diet and lifestyle patterns, including the consumption of alcohol and tobacco, stress levels, and obesity rates. In the United States, psoriasis affects approximately 3.2% of women and 2.8% of men, as per the data from a 2021 study and the 2020 U.S. census. This indicates that over 7.4 million people aged 20 and older are living with some form of psoriasis, including severe psoriasis, in the country.

Scope of the Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of severe psoriasis based on several factors.
• The Severe Psoriasis Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The report helps to identify the patient population, and the unmet needs of severe psoriasis are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

• What are the key findings of severe psoriasis epidemiology in the 8 major markets?
• What will be the total number of patients with severe psoriasis across the 8 major markets during the forecast period?
• What was the country-wise prevalence of severe psoriasis in the 8 major markets in the historical period?
• Which country will have the highest number of severe psoriasis patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of severe psoriasis during the forecast period of 2025-2034?
• What are the currently available treatments for severe psoriasis?
• What are the disease risks, signs, symptoms, and unmet needs of severe psoriasis?

This product will be delivered within 3-5 business days.